Citations (498)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (81)
Pierre Baumann, Philipp Bauknecht, Maxim Kuzin & Georgios Schoretsanitis. (2023) Switching antipsychotics to partial dopamine D2-agonists in individuals affected by schizophrenia: a narrative review. International Journal of Psychiatry in Clinical Practice 27:4, pages 367-384.
Read now
Read now
Stefano Bramante, Sylvia Rigardetto, Roberta Borgogno, Emina Mehanović, Luca Pellegrini, Umberto Albert & Giuseppe Maina. (2023) Episodic obsessive-compulsive disorder and bipolar spectrum disorder: new evidence from a large Italian OCD sample. International Journal of Psychiatry in Clinical Practice 27:4, pages 330-337.
Read now
Read now
Carl Hogstedt, Yvonne Forsell, Joseph F. Hayes, Margareta Torgén, Magnus Svartengren & Andreas Lundin. (2023) Long-term stability in obsessive thoughts and compulsive behavior in the general population: a longitudinal study in Sweden. Nordic Journal of Psychiatry 77:6, pages 574-580.
Read now
Read now
Borwin Bandelow, Christer Allgulander, David S. Baldwin, Daniel Lucas da Conceição Costa, Damiaan Denys, Nesrin Dilbaz, Katharina Domschke, Eric Hollander, Siegfried Kasper, Hans-Jürgen Möller, Elias Eriksson, Naomi A. Fineberg, Josef Hättenschwiler, Hisanobu Kaiya, Tatiana Karavaeva, Martin A. Katzman, Yong-Ku Kim, Takeshi Inoue, Leslie Lim, Vasilios Masdrakis, José M. Menchón, Euripedes C. Miguel, Antônio E. Nardi, Stefano Pallanti, Giampaolo Perna, Dan Rujescu, Vladan Starcevic, Dan J. Stein, Shih-Jen Tsai, Michael Van Ameringen, Anna Vasileva, Zhen Wang & Joseph Zohar. (2023) World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders – Version 3. Part II: OCD and PTSD. The World Journal of Biological Psychiatry 24:2, pages 118-134.
Read now
Read now
Borwin Bandelow, Christer Allgulander, David S. Baldwin, Daniel Lucas da Conceição Costa, Damiaan Denys, Nesrin Dilbaz, Katharina Domschke, Elias Eriksson, Naomi A. Fineberg, Josef Hättenschwiler, Eric Hollander, Hisanobu Kaiya, Tatiana Karavaeva, Siegfried Kasper, Martin Katzman, Yong-Ku Kim, Takeshi Inoue, Leslie Lim, Vasilios Masdrakis, José M. Menchón, Euripedes C. Miguel, Hans-Jürgen Möller, Antonio E. Nardi, Stefano Pallanti, Giampaolo Perna, Dan Rujescu, Vladan Starcevic, Dan J. Stein, Shih-Jen Tsai, Michael Van Ameringen, Anna Vasileva, Zhen Wang & Joseph Zohar. (2023) World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders – Version 3. Part I: Anxiety disorders. The World Journal of Biological Psychiatry 24:2, pages 79-117.
Read now
Read now
Satish Suhas, Palash Kumar Malo, Vijay Kumar, Thomas Gregor Issac, Nellai K. Chithra, Binukumar Bhaskarapillai, Y. C. Janardhan Reddy & Naren P. Rao. (2023) Treatment strategies for serotonin reuptake inhibitor-resistant obsessive-compulsive disorder: A network meta-analysis of randomised controlled trials. The World Journal of Biological Psychiatry 24:2, pages 162-177.
Read now
Read now
Sergio Machado, George Telles, Franklin Magalhaes, Diogo Teixeira, Sandra Amatriain-Fernández, Henning Budde, Claudio Imperatori, Eric Murillo-Rodriguez, Diogo Monteiro, Diogo Telles Correia & Alberto Souza Sá Filho. (2022) Can regular physical exercise be a treatment for panic disorder? A systematic review. Expert Review of Neurotherapeutics 22:1, pages 53-64.
Read now
Read now
Weiwei Liu, Hua Shao, Jing Liao, Dalu Yang, Maoliang Ma & Jianli Yang. (2021) Continuous Theta-Burst Stimulation Over the Right Orbitofrontal Cortex in Treatment-Resistant Obsessive-Compulsive Disorder Treatment: A Randomized Sham-Controlled Trial. International Journal of General Medicine 14, pages 3109-3118.
Read now
Read now
Ansab Akhtar & Sangeeta Pilkhwal Sah. (2021) Advances in the pharmacotherapeutic management of post-traumatic stress disorder. Expert Opinion on Pharmacotherapy 22:14, pages 1919-1930.
Read now
Read now
John J. Mariani, Martina Pavlicova, C. Jean Choi, Daniel J. Brooks, Amy L. Mahony, Zora Kosoff, Nasir Naqvi, Christina Brezing, Sean X. Luo & Frances R. Levin. (2021) An open-label pilot study of pregabalin pharmacotherapy for alcohol use disorder. The American Journal of Drug and Alcohol Abuse 47:4, pages 467-475.
Read now
Read now
Irma M Puspitasari, Rano K Sinuraya, Cherry Rahayu, Witriani Witriani, Uzlifatul Zannah, Auliani Hafifah, Ajeng R Ningtyas & Hilda Vildayanti. (2020) Medication Profile and Treatment Cost Estimation Among Outpatients with Schizophrenia, Bipolar Disorder, Depression, and Anxiety Disorders in Indonesia. Neuropsychiatric Disease and Treatment 16, pages 815-828.
Read now
Read now
Joseph V. Pergolizzi & Jo Ann LeQuang. (2020) Reappraising the use of benzodiazepines in chronic pain patients. Postgraduate Medicine 132:sup3, pages 10-12.
Read now
Read now
Rainer Rupprecht. (2020) Psychopharmacology- is there still room for progress in these days?. The World Journal of Biological Psychiatry 21:4, pages 239-240.
Read now
Read now
Antoine Pelissolo, Sandra Abou Kassm & Lauriane Delhay. (2019) Therapeutic strategies for social anxiety disorder: where are we now?. Expert Review of Neurotherapeutics 19:12, pages 1179-1189.
Read now
Read now
Siegfried Kasper. (2019) A thank-you note from the Chief-Editor. The World Journal of Biological Psychiatry 20:4, pages 254-257.
Read now
Read now
Gabriella Gobbi. (2019) A role for cannabidiol in psychiatry? Keep calm and follow the drug development rules. The World Journal of Biological Psychiatry 20:2, pages 98-100.
Read now
Read now
Julia Machado Khoury, Maila de Castro Lourenço das Neves, Marco Antônio Valente Roque, Daniela Alves de Brito Queiroz, André Augusto Corrêa de Freitas, Ângelo de Fátima, Fabrício A. Moreira & Frederico Duarte Garcia. (2019) Is there a role for cannabidiol in psychiatry?. The World Journal of Biological Psychiatry 20:2, pages 101-116.
Read now
Read now
Florence Thibaut, Abdeslam Chagraoui, Leslie Buckley, Florence Gressier, Javier Labad, Sandrine Lamy, Marc N. Potenza, Susan G. Kornstein, Marta Rondon, Anita Riecher-Rössler, Michael Soyka & Kim Yonkers. (2019) WFSBP and IAWMH Guidelines for the treatment of alcohol use disorders in pregnant women. The World Journal of Biological Psychiatry 20:1, pages 17-50.
Read now
Read now
Dana Kamaradova, Martin Brunovsky, Jan Prasko, Jiri Horacek, Miroslav Hajda, Ales Grambal & Klara Latalova. (2018) EEG correlates of induced anxiety in obsessive–compulsive patients: comparison of autobiographical and general anxiety scenarios. Neuropsychiatric Disease and Treatment 14, pages 2165-2174.
Read now
Read now
Ana Lusicic, Koen RJ Schruers, Stefano Pallanti & David J Castle. (2018) Transcranial magnetic stimulation in the treatment of obsessive–compulsive disorder: current perspectives. Neuropsychiatric Disease and Treatment 14, pages 1721-1736.
Read now
Read now
Heinz Grunze, Eduard Vieta, Guy M. Goodwin, Charles Bowden, Rasmus W. Licht, Jean-Michel Azorin, Lakshmi Yatham, Sergey Mosolov, Hans-Jürgen Möller & Siegfried Kasper. (2018) The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Acute and long-term treatment of mixed states in bipolar disorder. The World Journal of Biological Psychiatry 19:1, pages 2-58.
Read now
Read now
Eduard Maron & David Nutt. (2017) Biological markers of generalized anxiety disorder. Dialogues in Clinical Neuroscience 19:2, pages 147-158.
Read now
Read now
Borwin Bandelow, Sophie Michaelis & Dirk Wedekind. (2017) Treatment of anxiety disorders. Dialogues in Clinical Neuroscience 19:2, pages 93-107.
Read now
Read now
Michael Soyka, Henry R. Kranzler, Victor Hesselbrock, Siegfried Kasper, Jochen Mutschler & Hans-Jürgen Möller. (2017) Guidelines for biological treatment of substance use and related disorders, part 1: Alcoholism, first revision. The World Journal of Biological Psychiatry 18:2, pages 86-119.
Read now
Read now
Satoshi Asakura, Taiji Hayano, Atsushi Hagino & Tsukasa Koyama. (2016) Long-term administration of escitalopram in patients with social anxiety disorder in Japan. Neuropsychiatric Disease and Treatment 12, pages 1817-1825.
Read now
Read now
Rébecca Robillard & Addo Boafo. (2016) Etiopathology and neurobiology of obsessive-compulsive disorder: focus on biological rhythms and chronotherapy. ChronoPhysiology and Therapy 6, pages 29-40.
Read now
Read now
Borwin Bandelow, David Baldwin, Marianna Abelli, Carlo Altamura, Bernardo Dell’Osso, Katharina Domschke, Naomi A. Fineberg, Edna Grünblatt, Marek Jarema, Eduard Maron, David Nutt, Stefano Pini, Matilde M. Vaghi, Adam Wichniak, Gwyneth Zai & Peter Riederer. (2016) Biological markers for anxiety disorders, OCD and PTSD – a consensus statement. Part I: Neuroimaging and genetics. The World Journal of Biological Psychiatry 17:5, pages 321-365.
Read now
Read now
Satoshi Asakura, Taiji Hayano, Atsushi Hagino & Tsukasa Koyama. (2016) A randomized, double-blind, placebo-controlled study of escitalopram in patients with social anxiety disorder in Japan. Current Medical Research and Opinion 32:4, pages 749-757.
Read now
Read now
Rafael C. Freire, Morena M. Zugliani, Rafael F. Garcia & Antonio E. Nardi. (2016) Treatment–resistant panic disorder: a systematic review. Expert Opinion on Pharmacotherapy 17:2, pages 159-168.
Read now
Read now
Marco Grados, Michael Prazak, Aneeqa Saif & Andrew Halls. (2016) A review of animal models of obsessive-compulsive disorder: a focus on developmental, immune, endocrine and behavioral models. Expert Opinion on Drug Discovery 11:1, pages 27-43.
Read now
Read now
Bernardo Dell’Osso, Umberto Albert, Anna Rita Atti, Claudia Carmassi, Giuseppe Carrà, Fiammetta Cosci, Valeria Del Vecchio, Marco Di Nicola, Silvia Ferrari, Arianna Goracci, Felice Iasevoli, Mario Luciano, Giovanni Martinotti, Maria Giulia Nanni, Alessandra Nivoli, Federica Pinna, Nicola Poloni, Maurizio Pompili, Gaia Sampogna, Ilaria Tarricone, Sarah Tosato, Umberto Volpe & Andrea Fiorillo. (2015) Bridging the gap between education and appropriate use of benzodiazepines in psychiatric clinical practice. Neuropsychiatric Disease and Treatment 11, pages 1885-1909.
Read now
Read now
Borwin Bandelow & Sophie Michaelis. (2015) Epidemiology of anxiety disorders in the 21st century. Dialogues in Clinical Neuroscience 17:3, pages 327-335.
Read now
Read now
Alkomiet Hasan, Peter Falkai, Thomas Wobrock, Jeffrey Lieberman, Birte Glenthøj, Wagner F. Gattaz, Florence Thibaut & Hans-Jürgen Möller. (2015) World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia Part 3: Update 2015 Management of special circumstances: Depression, Suicidality, substance use disorders and pregnancy and lactation. The World Journal of Biological Psychiatry 16:3, pages 142-170.
Read now
Read now
Donatella Marazziti & Liliana Dell’Osso. (2015) Why have early investigational therapies of obsessive–compulsive disorder failed to materialise?. Expert Opinion on Investigational Drugs 24:4, pages 455-458.
Read now
Read now
Paweł Kawalec, Agnieszka Cierniak, Andrzej Pilc & Gabriel Nowak. (2015) Pregabalin for the treatment of social anxiety disorder. Expert Opinion on Investigational Drugs 24:4, pages 585-594.
Read now
Read now
Michael Bauer, Emanuel Severus, Stephan Köhler, Peter C. Whybrow, Jules Angst & Hans-Jürgen Möller. (2015) World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders. Part 2: Maintenance Treatment of Major Depressive Disorder-Update 2015. The World Journal of Biological Psychiatry 16:2, pages 76-95.
Read now
Read now
Takahiro Masuda, Takeshi Inoue, Yan An, Naoki Takamura, Shin Nakagawa, Yuji Kitaichi, Tsukasa Koyama & Ichiro Kusumi. (2014) Effect of the coadministration of citalopram with mirtazapine or atipamezole on rat contextual conditioned fear. Neuropsychiatric Disease and Treatment 10, pages 289-295.
Read now
Read now
Samira Toghanian, Marco DiBonaventura, Krister Järbrink & Julie C Locklear. (2014) Economic and humanistic burden of illness in generalized anxiety disorder: an analysis of patient survey data in Europe. ClinicoEconomics and Outcomes Research 6, pages 151-163.
Read now
Read now
Vladan Starcevic. (2014) The reappraisal of benzodiazepines in the treatment of anxiety and related disorders. Expert Review of Neurotherapeutics 14:11, pages 1275-1286.
Read now
Read now
Julia Diemer, Andreas Mühlberger, Paul Pauli & Peter Zwanzger. (2014) Virtual reality exposure in anxiety disorders: Impact on psychophysiological reactivity. The World Journal of Biological Psychiatry 15:6, pages 427-442.
Read now
Read now
Charlotte Both, Georg Kojda & Christian Lange-Asschenfeldt. (2014) Pharmacotherapy of generalized anxiety disorder: focus and update on pregabalin. Expert Review of Neurotherapeutics 14:1, pages 29-38.
Read now
Read now
Hedi Klila, Anne Chatton, Ariane Zermatten, Riaz Khan, Martin Preisig & Yasser Khazaal. (2013) Quality of Web-based information on obsessive compulsive disorder. Neuropsychiatric Disease and Treatment 9, pages 1717-1723.
Read now
Read now
Chuan Zou, Xiang Ding, Joseph H Flaherty & Birong Dong. (2013) Clinical efficacy and safety of fluoxetine in generalized anxiety disorder in Chinese patients. Neuropsychiatric Disease and Treatment 9, pages 1661-1670.
Read now
Read now
David S Baldwin, Khalil Ajel, Vasilios G Masdrakis, Magda Nowak & Rizwan Rafiq. (2013) Pregabalin for the treatment of generalized anxiety disorder: an update. Neuropsychiatric Disease and Treatment 9, pages 883-892.
Read now
Read now
. (2013) Abstracts. International Journal of Psychiatry in Clinical Practice 17:sup2, pages 1-39.
Read now
Read now
Michael Linden, Borwin Bandelow, Reinhard Joachim Boerner, Matthias Brasser, Siegfried Kasper, Hans-Jürgen Möller, Lena Pyrkosch, Hans-Peter Volz & Hans-Ulrich Wittchen. (2013) The best next drug in the course of generalized anxiety disorders: the “PN-GAD-algorithm”. International Journal of Psychiatry in Clinical Practice 17:2, pages 78-89.
Read now
Read now
Mohammad Sayyah, Sayeh Majzoob & Mehdi Sayyah. (2013) Metabolic and toxicological considerations for obsessive–compulsive disorder drug therapy. Expert Opinion on Drug Metabolism & Toxicology 9:6, pages 657-673.
Read now
Read now
K Outhoff. (2013) The pharmacology of anxiolytics. South African Family Practice 55:3, pages 223-229.
Read now
Read now
Heinz Grunze, Eduard Vieta, Guy M. Goodwin, Charles Bowden, Rasmus W. Licht, Hans-Jürgen Möller & Siegfried Kasper. (2013) The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2012 on the long-term treatment of bipolar disorder. The World Journal of Biological Psychiatry 14:3, pages 154-219.
Read now
Read now
Tiago A Mestre, Mateusz Zurowski & Susan H Fox. (2013) 5-Hydroxytryptamine 2A receptor antagonists as potential treatment for psychiatric disorders. Expert Opinion on Investigational Drugs 22:4, pages 411-421.
Read now
Read now
H. Parmentier, J. García-Campayo & R. Prieto. (2013) Comprehensive review of generalized anxiety disorder in primary care in Europe. Current Medical Research and Opinion 29:4, pages 355-367.
Read now
Read now
Alkomiet Hasan, Peter Falkai, Thomas Wobrock, Jeffrey Lieberman, Birte Glenthoj, Wagner F. Gattaz, Florence Thibaut & Hans-Jürgen Möller. (2013) World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 2: Update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects. The World Journal of Biological Psychiatry 14:1, pages 2-44.
Read now
Read now
Massimiliano Buoli, Alice Caldiroli, Elisabetta Caletti, Riccardo Augusto Paoli & Alfredo Carlo Altamura. (2013) New approaches to the pharmacological management of generalized anxiety disorder. Expert Opinion on Pharmacotherapy 14:2, pages 175-184.
Read now
Read now
Alain Gérard, François Liard, Anne Crochard, Sylvia Goni & Bruno Millet. (2012) Disability in patients consulting for anxiety or mood disorders in primary care: response to antidepressant treatment. Neuropsychiatric Disease and Treatment 8, pages 605-614.
Read now
Read now
Jean Endicott, Henrik Svedsäter & Julie C Locklear. (2012) Effects of once-daily extended release quetiapine fumarate on patient-reported outcomes in patients with generalized anxiety disorder. Neuropsychiatric Disease and Treatment 8, pages 301-311.
Read now
Read now
Ashutosh Sharma, Alexandre Cardoso-Taketa, Griselda García & María Luisa Villarreal. (2012) A systematic updated review of scientifically tested selected plants used for anxiety disorders. Botanics: Targets and Therapy 2, pages 21-39.
Read now
Read now
N Koen & DJ Stein. (2012) The assessment and treatment of panic disorder in general practice. South African Family Practice 54:6, pages 472-477.
Read now
Read now
David S. Baldwin, Christer Allgulander, Borwin Bandelow, Francisco Ferre & Stefano Pallanti. (2012) An international survey of reported prescribing practice in the treatment of patients with generalised anxiety disorder. The World Journal of Biological Psychiatry 13:7, pages 510-516.
Read now
Read now
Alkomiet Hasan, Peter Falkai, Thomas Wobrock, Jeffrey Lieberman, Birte Glenthoj, Wagner F. Gattaz, Florence Thibaut & Hans-Jürgen Möller. (2012) World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance. The World Journal of Biological Psychiatry 13:5, pages 318-378.
Read now
Read now
Panagiotis Oulis & George Konstantakopoulos. (2012) Efficacy and safety of pregabalin in the treatment of alcohol and benzodiazepine dependence. Expert Opinion on Investigational Drugs 21:7, pages 1019-1029.
Read now
Read now
Borwin Bandelow, Leo Sher, Robertas Bunevicius, Eric Hollander, Siegfried Kasper, Joseph Zohar & Hans-Jürgen Möller. (2012) Guidelines for the pharmacological treatment of anxiety disorders, obsessive–compulsive disorder and posttraumatic stress disorder in primary care. International Journal of Psychiatry in Clinical Practice 16:2, pages 77-84.
Read now
Read now
Nastassja Koen & Dan J. Stein. (2011) Pharmacotherapy of anxiety disorders: a critical review. Dialogues in Clinical Neuroscience 13:4, pages 423-437.
Read now
Read now
. (2011) Abstracts. International Journal of Psychiatry in Clinical Practice 15:sup2, pages 1-14.
Read now
Read now
Martin Aigner, Janet Treasure, Walter Kaye & Siegfried Kasper. (2011) World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Eating Disorders. The World Journal of Biological Psychiatry 12:6, pages 400-443.
Read now
Read now
Rafael C Freire, Jaime E Hallak, José A Crippa & Antonio E Nardi. (2011) New treatment options for panic disorder: clinical trials from 2000 to 2010. Expert Opinion on Pharmacotherapy 12:9, pages 1419-1428.
Read now
Read now
Michael Soyka, Henry R. Kranzler, Wim van den Brink, John Krystal, Hans-Jürgen Möller & Siegfried Kasper. (2011) The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Substance Use and Related Disorders. Part 2: Opioid dependence. The World Journal of Biological Psychiatry 12:3, pages 160-187.
Read now
Read now
Meredith G. Harris, Philip M. Burgess, Jane Pirkis, Dan Siskind, Tim Slade & Harvey A. Whiteford. (2011) Correlates of antidepressant and anxiolytic, hypnotic or sedative medication use in an Australian community sample. Australian and New Zealand Journal of Psychiatry 45:3, pages 249-260.
Read now
Read now
Ralf Ihl, Lutz Frölich, Bengt Winblad, Lon Schneider, Alistair Burns & Hans-Jürgen Möller. (2011) World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Alzheimer's disease and other dementias. The World Journal of Biological Psychiatry 12:1, pages 2-32.
Read now
Read now
Dirk Wedekind, Andreas Broocks, Nina Weiss, Kirsten Engel, Karin Neubert & Borwin Bandelow. (2010) A randomized, controlled trial of aerobic exercise in combination with paroxetine in the treatment of panic disorder. The World Journal of Biological Psychiatry 11:7, pages 904-913.
Read now
Read now
Fernanda Corrêa Coutinho, Gisele Pereira Dias, Mário Cesar do Nascimento Bevilaqua, Patricia Franca Gardino, Bernard Pimentel Rangé & Antonio Egidio Nardi. (2010) Current concept of anxiety: implications from Darwin to the DSM-V for the diagnosis of generalized anxiety disorder. Expert Review of Neurotherapeutics 10:8, pages 1307-1320.
Read now
Read now
Michael Kellner. (2010) Drug treatment of obsessive-compulsive disorder . Dialogues in Clinical Neuroscience 12:2, pages 187-197.
Read now
Read now
K Outhoff. (2010) The pharmacology of anxiolytics. South African Family Practice 52:2, pages 99-105.
Read now
Read now
Donatella Marazziti & Giorgio Consoli. (2010) Treatment strategies for obsessive-compulsive disorder. Expert Opinion on Pharmacotherapy 11:3, pages 331-343.
Read now
Read now
Heinz Grunze, Eduard Vieta, Guy M. Goodwin, Charles Bowden, Rasmus W. Licht, Hans-Jürgen Möller & Siegfried Kasper. (2010) The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression. The World Journal of Biological Psychiatry 11:2, pages 81-109.
Read now
Read now
B. Dell’Osso, M. Buoli, E. Hollander & A.C. Altamura. (2010) Duration of Untreated Illness as a Predictor of Treatment Response and Remission in Obsessive–Compulsive Disorder. The World Journal of Biological Psychiatry 11:1, pages 59-65.
Read now
Read now
Keming Gao, David V Sheehan & Joseph R Calabrese. (2009) Atypical antipsychotics in primary generalized anxiety disorder or comorbid with mood disorders. Expert Review of Neurotherapeutics 9:8, pages 1147-1158.
Read now
Read now
Siegfried Kasper. (2009) 9th International Forum on Mood and Anxiety Disorders. International Journal of Psychiatry in Clinical Practice 13:sup1, pages 6-22.
Read now
Read now
A. Carlo Altamura. (2009) Abstracts for the 3rd International Forum INNOPSY 09 (INNOVATION IN PSYCHIATRY) Impact of Early Intervention and Duration of Treatment on the Outcome of Psychiatric Disorders Milan, Italy, 18–20 November. International Journal of Psychiatry in Clinical Practice 13:sup2, pages 6-28.
Read now
Read now
Heinz Grunze, Eduard Vieta, Guy M. Goodwin, Charles Bowden, Rasmus W. Licht, Hans-Jürgen Möller, Siegfried Kasper, WFSBP Task Force on Treatment Guidelines for Bipolar Disorders, Heinz Grunze, Eduard Vieta, Guy M. Goodwin, Charles Bowden, Rasmus W. Licht, Hans-Jürgen Möller, Siegfried Kasper & WFSBP Task Force on Treatment Guidelines for Bipolar Disorders. (2009) The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2009 on the Treatment of Acute Mania. The World Journal of Biological Psychiatry 10:2, pages 85-116.
Read now
Read now
Chittaranjan Andrade. (2009) Ashwagandha for anxiety disorders. The World Journal of Biological Psychiatry 10:4-2, pages 686-687.
Read now
Read now
Savita G. Bhakta & Chittaranjan Andrade. (2009) Melatonin treatment of shoulder-and-neck dyskinesia possibly related to fluoxetine treatment. The World Journal of Biological Psychiatry 10:4-3, pages 1047-1048.
Read now
Read now
Articles from other publishers (417)
Sanghoon Oh, Sunwoo Cho, Sun-Young Moon, Junhee Lee, Minah Kim, Tae Young Lee & Jun Soo Kwon. (2024) Pharmacotherapy for obsessive-compulsive disorder: Real-world evidence from a 10-year retrospective data analysis. Asian Journal of Psychiatry 91, pages 103847.
Crossref
Crossref
Lance M. Rappaport, Emily Jerome, Michael Van Ameringen, Maureen Whittal & Carmen P. McLean. (2023) North American open-label 16-week trial of the MindShift smartphone app for adult anxiety. Journal of Mood & Anxiety Disorders 4, pages 100036.
Crossref
Crossref
Negin Eissazade, Hesam Mosavari, Shayan Eghdami, Mahsa Boroon, Faria Ashrafi & Mohammadreza Shalbafan. (2023) Efficacy and safety of 5-hydroxytryptamine-3 (5-HT3) receptor antagonists in augmentation with selective serotonin reuptake inhibitors (SSRIs) in the treatment of moderate to severe obsessive–compulsive disorder: a systematic review and meta-analysis of randomized clinical trials. Scientific Reports 13:1.
Crossref
Crossref
A. V. Vasileva, T. A. Karavaeva & D. S. Radionov. (2023) Pharmacotherapy algorithm for post-traumatic stress disorder. V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY 57:3, pages 80-91.
Crossref
Crossref
Eun Hyun Seo, Seung-Gon Kim, Jae-Hon Lee & Hyung-Jun Yoon. (2023) Successful Early Lamotrigine and Aripiprazole Augmentation of Clomipramine in Severe Obsessive-compulsive Disorder. Clinical Psychopharmacology and Neuroscience 21:3, pages 604-608.
Crossref
Crossref
Fatima Ramos-Marcuse & Karan Kverno. (2023) Treatment in Children and Adolescents With Obsessive-Compulsive Disorder: Review for Practitioners. Journal of Psychosocial Nursing and Mental Health Services 61:8, pages 11-15.
Crossref
Crossref
Tammy Hua, Lori S. Kim, Muhammad Yousaf, Eran C. Gwillim, Yik W. Yew, Brad Lee, Kevin Hua, Taylor Erickson, Brian Cheng, Kevin Patel & Jonathan Ian Silverberg. (2023) Psychological Interventions Are More Effective Than Educational Interventions at Improving Atopic Dermatitis Severity: A Systematic Review. Dermatitis® 34:4, pages 301-307.
Crossref
Crossref
A. V. Vasileva, T. A. Karavaeva & D. S. Radionov. (2023) Pharmacotherapy algorithm for post-traumatic stress disorder. V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY.
Crossref
Crossref
Jessica D. Leuchter, Minjee Kook, Daniel A. Geller, Alyssa G. Hertz, Jessica Garcia, Erika S. Trent, Tracey Dibbs, Ogechi Onyeka, Wayne K. Goodman, Andrew G. Guzick, Andrew D. Wiese, Amanda D. Palo, Brent J. Small, H. Blair Simpson, Lauren K. Havel, Sohail A. Nibras, Kirti Saxena & Eric A. Storch. (2023) Promoting OCD WEllness and resilience (POWER) study: Rationale, design, and methods. Psychiatry Research Communications 3:2, pages 100111.
Crossref
Crossref
Tim Carter. (2023) Understanding the presentation and treatment of anxiety disorders. Nursing Standard 38:6, pages 73-77.
Crossref
Crossref
Mary Princip, Katharina Ledermann & Roland von Känel. (2023) Posttraumatic Stress Disorder as a Consequence of Acute Cardiovascular Disease. Current Cardiology Reports.
Crossref
Crossref
Brittany Finocchio & Wanda Hilliard. (2023) Use of Objective Rating Scales for Generalized Anxiety by Psychiatry Specialists in Pediatric Populations: A Research Review. Journal of Psychosocial Nursing and Mental Health Services 61:5, pages 11-16.
Crossref
Crossref
A. V. Vasileva. (2023) Post-traumatic stress disorder – from traumatic neurosis to ICD-11: features of diagnosis and selection of therapy. Meditsinskiy sovet = Medical Council:3, pages 94-108.
Crossref
Crossref
Christopher Pittenger. (2023) The Pharmacological Treatment of Obsessive-Compulsive Disorder. Psychiatric Clinics of North America 46:1, pages 107-119.
Crossref
Crossref
Peter Kyriakoulis & Michael Kyrios. (2023) Biological and cognitive theories explaining panic disorder: A narrative review. Frontiers in Psychiatry 14.
Crossref
Crossref
Ung Gu Kang, Se Hyun Kim, Young Sook Choi, Kyu Young Lee, Yong Sik Kim & In Won Chung. (2023) Practical Issues With Clonazepam Use. Journal of Korean Neuropsychiatric Association 62:1, pages 21.
Crossref
Crossref
Peter J. van Roessel, Giacomo Grassi, Elias N. Aboujaoude, José M. Menchón, Michael Van Ameringen & Carolyn I. Rodríguez. (2023) Treatment-resistant OCD: Pharmacotherapies in adults. Comprehensive Psychiatry 120, pages 152352.
Crossref
Crossref
Adeleh Askari Diarjani & Seyed Alireza Haji Seyed Javadi. (2022) The effect of low-frequency repetitive transcranial magnetic stimulation on left dorsolateral prefrontal cortex in patients with the obsessive-compulsive disorder: a double-blinded, sham-controlled clinical trial. Middle East Current Psychiatry 29:1.
Crossref
Crossref
Chris Paxos. (2022) Moving beyond first-line treatment options for OCD. Mental Health Clinician 12:5, pages 300-308.
Crossref
Crossref
Luca Pellegrini, Kabir Garg, Arun Enara, David Shimon Gottlieb, David Wellsted, Umberto Albert, Keith R. Laws & Naomi A. Fineberg. (2022) Repetitive transcranial magnetic stimulation (r-TMS) and selective serotonin reuptake inhibitor-resistance in obsessive-compulsive disorder: A meta-analysis and clinical implications. Comprehensive Psychiatry 118, pages 152339.
Crossref
Crossref
Cosmin Octavian Popa, Florin Alin Sava, Simona Muresan, Alina Schenk, Cristiana Manuela Cojocaru, Lorena Mihaela Muntean & Peter Olah. (2022) Standard CBT versus integrative and multimodal CBT assisted by virtual-reality for generalized anxiety disorder. Frontiers in Psychology 13.
Crossref
Crossref
F. Montavon, F. Vandenberghe & C.B. Eap. (2022) Use of pharmacological treatment for posttraumatic stress disorder: Analysis of a psychiatric population in Switzerland and comparison with international guidelines. L'Encéphale.
Crossref
Crossref
Shabah M. Shadli, Robert G. Delany, Paul Glue & Neil McNaughton. (2022) Right Frontal Theta: Is It a Response Biomarker for Ketamine’s Therapeutic Action in Anxiety Disorders?. Frontiers in Neuroscience 16.
Crossref
Crossref
Takuma Nishijo, Etsuko Suzuki & Toshihiko Momiyama. (2022)
Serotonin 5‐HT
1A
and 5‐HT
1B
receptor‐mediated inhibition of glutamatergic transmission onto rat basal forebrain cholinergic neurones
. The Journal of Physiology 600:13, pages 3149-3167.
Crossref
Crossref
Borwin Bandelow, Antonia M. Werner, Ina Kopp, Sebastian Rudolf, Jörg Wiltink & Manfred E. Beutel. (2021) The German Guidelines for the treatment of anxiety disorders: first revision. European Archives of Psychiatry and Clinical Neuroscience 272:4, pages 571-582.
Crossref
Crossref
Ghazi I. Al Jowf, Ziyad T. Ahmed, Ning An, Rick A. Reijnders, Elena Ambrosino, Bart P. F. Rutten, Laurence de Nijs & Lars M. T. Eijssen. (2022) A Public Health Perspective of Post-Traumatic Stress Disorder. International Journal of Environmental Research and Public Health 19:11, pages 6474.
Crossref
Crossref
Sirui Yan, Hailong Liu, Yaqiong Yu, Nashu Han & Wenzhi Du. (2022) Changes of Serum Homocysteine and Vitamin B12, but Not Folate Are Correlated With Obsessive-Compulsive Disorder: A Systematic Review and Meta-Analysis of Case-Control Studies. Frontiers in Psychiatry 13.
Crossref
Crossref
Anton V. Malyshev, Iuliia A. Sukhanova, Valeria M. Ushakova, Yana A. Zorkina, Olga V. Abramova, Anna Y. Morozova, Eugene A. Zubkov, Nikita A. Mitkin, Vsevolod V. Pavshintsev, Igor I. Doronin, Vasilina R. Gedzun, Gennady A. Babkin, Sergio A. Sanchez, Miah D. Baker & Colin N. Haile. (2022) Peptide LCGA-17 Attenuates Behavioral and Neurochemical Deficits in Rodent Models of PTSD and Depression. Pharmaceuticals 15:4, pages 462.
Crossref
Crossref
Simon JC Davies, David Rudoler, Claire de Oliveira, Anjie Huang, Paul Kurdyak & Andrea Iaboni. (2022) Comparative safety of chronic versus intermittent benzodiazepine prescribing in older adults: A population-based cohort study. Journal of Psychopharmacology 36:4, pages 460-469.
Crossref
Crossref
Taryn Williams, Nicole J Phillips, Dan J Stein & Jonathan C Ipser. (2022) Pharmacotherapy for post traumatic stress disorder (PTSD). Cochrane Database of Systematic Reviews 2022:3.
Crossref
Crossref
Ahmet Oguzhan Bicakci, Mousumi Sarkar, Yu-Hsin Chang, Evelyn Kahl, Lorenzo Ragazzi, Angel Moldes-Anaya & Markus Fendt. (2022) Anxiolytic-like Effects of the Positive GABAB Receptor Modulator GS39783 Correlate with Mice’s Individual Basal Anxiety and Stress Reactivity. Pharmaceuticals 15:2, pages 233.
Crossref
Crossref
Michael Mosley, Hong-An Ngo & Tara Arbogast. (2022) Among people with anxiety, what is the effective duration of SSRI therapy to prevent relapse?. Evidence-Based Practice 25:2, pages 33-34.
Crossref
Crossref
Penghui Song, Han Tong, Luyan Zhang, Hua Lin, Ningning Hu, Xin Zhao, Wensi Hao, Peng Xu & Yuping Wang. (2022) Repetitive Transcranial Magnetic Stimulation Modulates Frontal and Temporal Time-Varying EEG Network in Generalized Anxiety Disorder: A Pilot Study. Frontiers in Psychiatry 12.
Crossref
Crossref
A.V. Vasileva. (2022) Post-traumatic stress disorder in the focus of international research: from soldier heart to ICD-11. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 122:10, pages 72.
Crossref
Crossref
Reza Yakhkeshi, Fatemeh Roshani, Kobra Akhoundzadeh & Sakineh Shafia. (2022) Effect of treadmill exercise on serum corticosterone, serum and hippocampal BDNF, hippocampal apoptosis and anxiety behavior in an ovariectomized rat model of post-traumatic stress disorder (PTSD). Physiology & Behavior 243, pages 113629.
Crossref
Crossref
Markus Dold, Lucie Bartova, Gernot Fugger, Marleen MM Mitschek, Chiara Fabbri, Alessandro Serretti, Julien Mendlewicz, Daniel Souery, Joseph Zohar, Stuart Montgomery & Siegfried Kasper. (2022) Pregabalin augmentation of antidepressants in major depression - results from a European multicenter study. Journal of Affective Disorders 296, pages 485-492.
Crossref
Crossref
Shoumitro Shoumi Deb, Marco O. Bertelli & Michele Rossi. 2022. Textbook of Psychiatry for Intellectual Disability and Autism Spectrum Disorder. Textbook of Psychiatry for Intellectual Disability and Autism Spectrum Disorder
247
279
.
Leopold Maria Lautenbacher, Lena Pyrkosch, Lea Mascarell Maricic & Andreas Ströhle. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
2243
2259
.
Victor M. Tang & Simon J. C. Davies. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
2217
2242
.
Michael-Roy R. Durr, Susan Petryk, Mansfield Mela, Andrea DesRoches, Mackenzie Wekerle & Sanjida Newaz. (2021) Utilization of psychotropic medications in children with FASD: a retrospective review. BMC Pediatrics 21:1.
Crossref
Crossref
Joseph M. StrayhornJr.Jr.. (2021) Virtual controls as an alternative to randomized controlled trials for assessing efficacy of interventions. BMC Medical Research Methodology 21:1.
Crossref
Crossref
Mingming Niu, Ya Gao, Min Yang, Yonggang Zhang, Jie Geng, Ziwei Song, Yamin Chen, Yanchen Li, Jiang Li & Jinhui Tian. (2021) The quality and clinical applicability of recommendations in anxiety disorders guidelines: A systematic review of seventeen guidelines from seven countries. Journal of Affective Disorders 295, pages 1301-1309.
Crossref
Crossref
Shabir Ahmad Dar, Rayees Ahmad Wani & Inaamul Haq. (2021) A Comparative Study of Aripiprazole, Olanzapine, and L-Methylfolate Augmentation in Treatment Resistant Obsessive-Compulsive Disorder. Psychiatric Quarterly 92:4, pages 1413-1424.
Crossref
Crossref
Andrey A. Ivashchenko, Margarita A. Morozova, Natalia V. Vostokova, Allan G. Beniashvily, Olga A. Bukhanovskaya, Denis S. Burminskiy, Alina N. Egorova, Lubov Y. Gluskina, Dmitriy S. Gorchakov, Ruben N. Karapetian, Lala N. Kasimova, Dmitry V. Kravchenko, Taissia A. Lepilkina, Elena A. Merkulova, Oleg D. Mitkin, Nataliya A. Penchul, Sergey S. Potanin, George E. Rupchev & Alexandre V. Ivachtchenko. (2021) Safety and efficacy of aviandr in patients with generalized anxiety disorder: A multicenter, randomized, double-blind, placebo-controlled, dose-finding, pilot study. Journal of Psychiatric Research 143, pages 436-444.
Crossref
Crossref
Gang Wang, Tianmei Si, Joseph S. Imperato, LiLi Yang, Kelly H. Zou, Ying Olive Jin, Elizabeth A. Pappadopulos, Lei Yan, Jim Z. Li & Wei Yu. (2021) Impact of sertraline daily treatment regimen on adherence, persistence and healthcare resource utilisation in patients with major depressive disorder or obsessive‐compulsive disorder: A real‐world evidence analysis from the United States. International Journal of Clinical Practice 75:10.
Crossref
Crossref
Hong Cai, Yu Jin, Shou Liu, Qinge Zhang, Ling Zhang, Teris Cheung, Lloyd Balbuena & Yu-Tao Xiang. (2021) Prevalence of suicidal ideation and planning in patients with major depressive disorder: A meta-analysis of observation studies. Journal of Affective Disorders 293, pages 148-158.
Crossref
Crossref
Alicia Martin, Mark Naunton, Sam Kosari, Gregory Peterson, Jackson Thomas & Julia K. Christenson. (2021) Treatment Guidelines for PTSD: A Systematic Review. Journal of Clinical Medicine 10:18, pages 4175.
Crossref
Crossref
Tomofumi Watanabe & Kazuhiro Sakamoto. (2021) Meta-analysis of cognitive and behavioral tests in leptin- and leptin receptor-deficient mice. Neuroscience Research 170, pages 217-235.
Crossref
Crossref
Anderson Camargo, Ana Paula Dalmagro, Daiane B. Fraga, Julia M. Rosa, Ana Lúcia B. Zeni, Manuella P. Kaster & Ana Lúcia S. Rodrigues. (2021) Low doses of ketamine and guanosine abrogate corticosterone-induced anxiety-related behavior, but not disturbances in the hippocampal NLRP3 inflammasome pathway. Psychopharmacology 238:9, pages 2555-2568.
Crossref
Crossref
Anton V. Malyshev, Iuliia A. Sukhanova, Alexander S. Zlobin, Vasilina R. Gedzun, Vsevolod V. Pavshintsev, Ekaterina V. Vasileva, Arthur O. Zalevsky, Igor I. Doronin, Nikita A. Mitkin, Andrey V. Golovin, Maxim L. Lovat, Georgy I. Kovalev, Yurii A. Zolotarev, Askar R. Kuchumov, Gennady A. Babkin & Bernhard Luscher. (2021) In silico Screening and Behavioral Validation of a Novel Peptide, LCGA-17, With Anxiolytic-Like Properties. Frontiers in Neuroscience 15.
Crossref
Crossref
Norma Verdolini, Diego Hidalgo‐Mazzei, Laura Del Matto, Michele Muscas, Isabella Pacchiarotti, Andrea Murru, Ludovic Samalin, Alberto Aedo, Mauricio Tohen, Heinz Grunze, Allan H. Young, André F. Carvalho & Eduard Vieta. (2021) Long‐term treatment of bipolar disorder type I: A systematic and critical review of clinical guidelines with derived practice algorithms. Bipolar Disorders 23:4, pages 324-340.
Crossref
Crossref
Ymkje Anna de Vries, Meredith G. Harris, Daniel Vigo, Wai Tat Chiu, Nancy A. Sampson, Ali Al-Hamzawi, Jordi Alonso, Laura H. Andrade, Corina Benjet, Ronny Bruffaerts, Brendan Bunting, José Miguel Caldas de Almeida, Giovanni de Girolamo, Silvia Florescu, Oye Gureje, Josep Maria Haro, Chiyi Hu, Elie G. Karam, Norito Kawakami, Viviane Kovess-Masfety, Sing Lee, Jacek Moskalewicz, Fernando Navarro-Mateu, Akin Ojagbemi, José Posada-Villa, Kate Scott, Yolanda Torres, Zahari Zarkov, Andrew Nierenberg, Ronald C. Kessler & Peter de Jonge. (2021) Perceived helpfulness of treatment for specific phobia: Findings from the World Mental Health Surveys. Journal of Affective Disorders 288, pages 199-209.
Crossref
Crossref
Wicher A. Bokma, Neeltje M. Batelaan, Brenda W.J.H. Penninx & Anton J.L.M. van Balkom. (2021) Evaluating a dimensional approach to treatment resistance in anxiety disorders: A two-year follow-up study. Journal of Affective Disorders Reports 4, pages 100139.
Crossref
Crossref
Atul R. Chopade, Prakash M. Somade, Pratik P. Somade & Suraj N. Mali. (2020) Identification of Anxiolytic Potential of Niranthin: In-vivo and Computational Investigations. Natural Products and Bioprospecting 11:2, pages 223-233.
Crossref
Crossref
Elyse M. Cornett, Sam N. Amarasinghe, Alexis Angelette, Tunde Abubakar, Adam M. Kaye, Alan David Kaye, Elisa E. Neuchat, Ivan Urits & Omar Viswanath. (2021) VALTOCO® (Diazepam Nasal Spray) for the Acute Treatment of Intermittent Stereotypic Episodes of Frequent Seizure Activity. Neurology International 13:1, pages 64-78.
Crossref
Crossref
Lotta Winter, Assel Saryyeva, Kerstin Schwabe, Hans E. Heissler, Joachim Runge, Mesbah Alam, Ivo Heitland, Kai G. Kahl & Joachim K. Krauss. (2021) Long-Term Deep Brain Stimulation in Treatment-Resistant Obsessive-Compulsive Disorder: Outcome and Quality of Life at Four to Eight Years Follow-Up. Neuromodulation: Technology at the Neural Interface 24:2, pages 324-330.
Crossref
Crossref
Alicia Martin, Sam Kosari, Gregory M. Peterson, Jackson Thomas, Philip Morris & Mark Naunton. (2020) Pharmacological management of post‐traumatic stress disorder and its associated nightmares: A survey of psychiatrists. Journal of Clinical Pharmacy and Therapeutics 46:1, pages 158-165.
Crossref
Crossref
Catherine Pétein, Anne Spinewine & Séverine Henrard. (2021) Trends in benzodiazepine receptor agonists use and associated factors in the Belgian general older population: analysis of the Belgian health interview survey data. Therapeutic Advances in Psychopharmacology 11, pages 204512532110118.
Crossref
Crossref
Vasilios G. Masdrakis & David S. Baldwin. (2021) Anticonvulsant and antipsychotic medications in the pharmacotherapy of panic disorder: a structured review. Therapeutic Advances in Psychopharmacology 11, pages 204512532110023.
Crossref
Crossref
Antonio Inserra, Danilo De Gregorio & Gabriella Gobbi. (2020) Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms. Pharmacological Reviews 73:1, pages 202-277.
Crossref
Crossref
Mehmet Kemal Arıkan, Mehmet Güven Günver & Reyhan İlhan. (2021) Gamma oscillations predict paroxetine response of patients with Obsessive Compulsive Disorder. Journal of Obsessive-Compulsive and Related Disorders 28, pages 100620.
Crossref
Crossref
Belinda R. Walsh. (2021) A critical review of the evidence for the equivalence of canine and human compulsions. Applied Animal Behaviour Science 234, pages 105166.
Crossref
Crossref
Leopold Maria Lautenbacher, Lena Pyrkosch, Lea Mascarell Maricic & Andreas Ströhle. 2020. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
1
17
.
Victor M. Tang & Simon J. C. Davies. 2020. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
1
26
.
Donna R. Zwas, Andre Keren, Offer Amir & Israel Gotsman. (2020) Treatment of Heart Failure Patients with Anxiolytics Is Associated with Adverse Outcomes, with and without Depression. Journal of Clinical Medicine 9:12, pages 3967.
Crossref
Crossref
Veronica B. Maphanga, Krystyna Skalicka-Woźniak, Barbara Budzynska, Gill M. Enslin & Alvaro M. Viljoen. (2020) Screening selected medicinal plants for potential anxiolytic activity using an in vivo zebrafish model. Psychopharmacology 237:12, pages 3641-3652.
Crossref
Crossref
Srinivas Balachander, Aakash Bajaj, Nandita Hazari, Ajay Kumar, Nitin Anand, M. Manjula, Paulomi M. Sudhir, Anish V. Cherian, Janardhanan C. Narayanaswamy, T. S. Jaisoorya, Suresh Bada Math, Thennarasu Kandavel, Shyam Sundar Arumugham & Y. C. Janardhan Reddy. (2020) Long-term Outcomes of Intensive Inpatient Care for Severe, Resistant Obsessive-Compulsive Disorder: Résultats à long terme de soins intensifs à des patients hospitalisés pour un trouble obsessionnel-compulsif grave et résistant. The Canadian Journal of Psychiatry 65:11, pages 779-789.
Crossref
Crossref
Geoffrey de Brouwer, Arina Fick, Ané Lombaard, Dan J. Stein, Brian H. Harvey & De Wet Wolmarans. (2020) Large nest building and high marble-burying: Two compulsive-like phenotypes expressed by deer mice (Peromyscus maniculatus bairdii) and their unique response to serotoninergic and dopamine modulating intervention. Behavioural Brain Research 393, pages 112794.
Crossref
Crossref
Austin W. Blum & Jon E. Grant. 2020. The Cambridge Handbook of Substance and Behavioral Addictions. The Cambridge Handbook of Substance and Behavioral Addictions
373
385
.
. 2020. The Cambridge Handbook of Substance and Behavioral Addictions. The Cambridge Handbook of Substance and Behavioral Addictions
295
425
.
. 2020. The Cambridge Handbook of Substance and Behavioral Addictions. The Cambridge Handbook of Substance and Behavioral Addictions.
Mansfield Mela, Ana Hanlon-Dearman, A. G. Ahmed, Susan D. Rich, Rod Densmore, Dorothy Reid, Alasdair M. Barr, David Osser, Tara Anderson, Bola Suberu, Osman Ipsiroglu, Hasu Rajani & Christine Loock. (2020) Treatment algorithm for the use of psychopharmacological agents in individuals prenatally exposed to alcohol and/or with diagnosis of fetal alcohol spectrum disorder (FASD). Journal of Population Therapeutics & Clinical Pharmacology 27:3, pages e1-e13.
Crossref
Crossref
Guy A. Higgins, Matt Brown, Jessica St John, Cam MacMillan, Leo B. Silenieks & Sandy Thevarkunnel. (2020) Effects of 5-HT2C receptor modulation and the NA reuptake inhibitor atomoxetine in tests of compulsive and impulsive behaviour. Neuropharmacology 170, pages 108064.
Crossref
Crossref
Michał Lew-Starowicz, Karol Lewczuk, Iwona Nowakowska, Shane Kraus & Mateusz Gola. (2020) Compulsive Sexual Behavior and Dysregulation of Emotion. Sexual Medicine Reviews 8:2, pages 191-205.
Crossref
Crossref
Katsunori Kobayashi, Yasunori Mikahara, Yuka Murata, Daiki Morita, Sumire Matsuura, Eri Segi-Nishida & Hidenori Suzuki. (2020) Predominant Role of Serotonin at the Hippocampal Mossy Fiber Synapse with Redundant Monoaminergic Modulation. iScience 23:4, pages 101025.
Crossref
Crossref
Sun-Young Kim, Kang-Seob Oh, Dong-Won Shin, Weon-Jeong Lim, Sang-Won Jeon, Eun-Jin Kim, Sung Joon Cho & Young-Chul Shin. (2020) The association of physical activity and sleep duration with incident anxiety symptoms: A cohort study of 134,957 Korean adults. Journal of Affective Disorders 265, pages 305-313.
Crossref
Crossref
Li-Juan Zhu, Lei Chang, Hu-Jiang Shi & Na Li. (2020) Systemic administration of ZLc-002 exerts anxiolytic-like effects by dissociation of nNOS from CAPON in adult mice. Biochemical and Biophysical Research Communications 523:2, pages 299-306.
Crossref
Crossref
Wicher A Bokma, Neeltje M Batelaan, Adriaan W Hoogendoorn, Brenda WJH Penninx & Anton JLM van Balkom. (2019) A clinical staging approach to improving diagnostics in anxiety disorders: Is it the way to go?. Australian & New Zealand Journal of Psychiatry 54:2, pages 173-184.
Crossref
Crossref
Akira Ninomiya, Mitsuhiro Sado, Sunre Park, Daisuke Fujisawa, Teppei Kosugi, Atsuo Nakagawa, Joichiro Shirahase & Masaru Mimura. (2019) Effectiveness of mindfulness‐based cognitive therapy in patients with anxiety disorders in secondary‐care settings: A randomized controlled trial. Psychiatry and Clinical Neurosciences 74:2, pages 132-139.
Crossref
Crossref
Andrew T. Gloster, Marcia T.B. Rinner, Myria Ioannou, Jeanette Villanueva, Victoria J. Block, Giovanna Ferrari, Charles Benoy, Klaus Bader & Maria Karekla. (2020) Treating treatment non-responders: A meta-analysis of randomized controlled psychotherapy trials. Clinical Psychology Review 75, pages 101810.
Crossref
Crossref
Rodolfo Rossi, Cinzia Niolu, Alberto Siracusano, Alessandro Rossi & Giorgio Di Lorenzo. (2020) A Case of Comorbid PTSD and Posttraumatic OCD Treated with Sertraline-Aripiprazole Augmentation. Case Reports in Psychiatry 2020, pages 1-4.
Crossref
Crossref
Shivanee Kumari, Aseem Mehra & Sandeep Grover. (2020) Peripheral edema associated with low dose of pregabalin in an older person. Journal of Geriatric Mental Health 7:2, pages 105.
Crossref
Crossref
Ning Ding, Linzhi Li, Kai Song, Ailing Huang & Hong Zhang. (2020) Efficacy and safety of acupuncture in treating post-traumatic stress disorder. Medicine 99:26, pages e20700.
Crossref
Crossref
Maria Célia Mendes & Marcos Felipe Silva de Sá. (2020) The Use of Antidepressant Drugs in Climacteric Syndrome. Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics 42:01, pages 001-004.
Crossref
Crossref
Vladimir Trkulja & Hrvoje Barić. 2020. Anxiety Disorders. Anxiety Disorders
415
449
.
O. M. Hendawy, Khalid Saad Alharbi, Della Thomas Grace Parmbi, Mohammed Salem Alshammari & Mohammad Ajmal Shah. 2020. Principles of Neurochemistry. Principles of Neurochemistry
171
184
.
Marco Antonio Caldieraro, Marco Maiello, Olivia Losiewicz & Paolo Cassano. 2020. Clinical Handbook of Anxiety Disorders. Clinical Handbook of Anxiety Disorders
283
295
.
M Mofizul Islam. (2019) Pattern and probability of dispensing of prescription opioids and benzodiazepines among the new users in Australia: a retrospective cohort study. BMJ Open 9:12, pages e030803.
Crossref
Crossref
Antonino Naro, Luana Billeri, Antonino Cannavò, Rosaria De Luca, Simona Portaro, Placido Bramanti & Rocco Salvatore Calabrò. (2019) Theta burst stimulation for the treatment of obsessive–compulsive disorder: a pilot study. Journal of Neural Transmission 126:12, pages 1667-1677.
Crossref
Crossref
Daniela Mier, Frederike Schirmbeck, Gabriela Stoessel, Christine Esslinger, Franziska Rausch, Susanne Englisch, Sarah Eisenacher, Lieuwe de Haan, Andreas Meyer-Lindenberg, Peter Kirsch & Mathias Zink. (2018) Reduced activity and connectivity of left amygdala in patients with schizophrenia treated with clozapine or olanzapine. European Archives of Psychiatry and Clinical Neuroscience 269:8, pages 931-940.
Crossref
Crossref
Milica Stanojevic & Dragan Panic. (2019) Treatment of Anxiety Disorders - The Role of Pharmacists. Serbian Journal of Experimental and Clinical Research 0:0.
Crossref
Crossref
Laiana A Quagliato, Fiammetta Cosci, Richard I Shader, Edward K Silberman, Vladan Starcevic, Richard Balon, Steven L Dubovsky, Carl Salzman, John H Krystal, Steve J Weintraub, Rafael C Freire & Antonio E Nardi. (2019) Selective serotonin reuptake inhibitors and benzodiazepines in panic disorder: A meta-analysis of common side effects in acute treatment. Journal of Psychopharmacology 33:11, pages 1340-1351.
Crossref
Crossref
Wicher A. Bokma, Guido A. A. M. Wetzer, Jurriaan B. Gehrels, Brenda W. J. H. Penninx, Neeltje M. Batelaan & Anton L. J. M. Balkom. (2019) Aligning the many definitions of treatment resistance in anxiety disorders: A systematic review. Depression and Anxiety 36:9, pages 801-812.
Crossref
Crossref
Sonja Cabarkapa, Joel A. King, Nathan Dowling & Chee H. Ng. (2019) Co-Morbid Obsessive–Compulsive Disorder and Attention Deficit Hyperactivity Disorder: Neurobiological Commonalities and Treatment Implications. Frontiers in Psychiatry 10.
Crossref
Crossref
Dan J. Stein, Daniel L. C. Costa, Christine Lochner, Euripedes C. Miguel, Y. C. Janardhan Reddy, Roseli G. Shavitt, Odile A. van den Heuvel & H. Blair Simpson. (2019) Obsessive–compulsive disorder. Nature Reviews Disease Primers 5:1.
Crossref
Crossref
Chiara Rapinesi, Georgios D. Kotzalidis, Stefano Ferracuti, Gabriele Sani, Paolo Girardi & Antonio Del Casale. (2019) Brain Stimulation in Obsessive-Compulsive Disorder (OCD): A Systematic Review. Current Neuropharmacology 17:8, pages 787-807.
Crossref
Crossref
Antonio Del Casale, Serena Sorice, Alessio Padovano, Maurizio Simmaco, Stefano Ferracuti, Dorian A. Lamis, Chiara Rapinesi, Gabriele Sani, Paolo Girardi, Georgios D. Kotzalidis & Maurizio Pompili. (2019) Psychopharmacological Treatment of Obsessive-Compulsive Disorder (OCD). Current Neuropharmacology 17:8, pages 710-736.
Crossref
Crossref
Andrew C Naglich, Sara Bozeman, E Sherwood Brown & Bryon Adinoff. (2019) Effect of Selective Serotonin Reuptake Inhibitors on Healthcare Utilization in Patients with Post-Traumatic Stress Disorder and Alcohol Use Disorder. Alcohol and Alcoholism 54:4, pages 428-434.
Crossref
Crossref
Francesco Perris, Michele Fabrazzo, Valeria De Santis, Mario Luciano, Gaia Sampogna, Andrea Fiorillo & Francesco Catapano. (2019) Comorbidity of Obsessive-Compulsive Disorder and Schizotypal Personality Disorder: Clinical Response and Treatment Resistance to Pharmacotherapy in a 3-Year Follow-Up Naturalistic Study. Frontiers in Psychiatry 10.
Crossref
Crossref
Mohamed S. Zulfarina, Syed-Badrul Syarifah-Noratiqah, Shuid A. Nazrun, Razinah Sharif & Isa Naina-Mohamed. (2019) Pharmacological Therapy in Panic Disorder: Current Guidelines and Novel Drugs Discovery for Treatment-resistant Patient. Clinical Psychopharmacology and Neuroscience 17:2, pages 145-154.
Crossref
Crossref
Laura Weiss Roberts, Robert E. Hales & Stuart C. YudofskyDarin Dougherty, Sabine Wilhelm & Michael Jenike. 2019. The American Psychiatric Association Publishing Textbook of Psychiatry. The American Psychiatric Association Publishing Textbook of Psychiatry.
Umberto Albert, Francesca Barbaro, Stefano Bramante, Gianluca Rosso, Diana De Ronchi & Giuseppe Maina. (2019) Duration of untreated illness and response to SRI treatment in Obsessive-Compulsive Disorder. European Psychiatry 58, pages 19-26.
Crossref
Crossref
Vera De Carlo, Benedetta Grancini, Matteo Vismara, Beatrice Benatti, Chiara Arici, Laura Cremaschi, Giovanna Cirnigliaro, Luca Degoni, Lucio Oldani, Carlotta Palazzo, Ira D. Glick, Caterina Viganò & Bernardo Dell'Osso. (2019) Exploring characteristics associated with first benzodiazepine prescription in patients with affective disorders and related diagnoses. Human Psychopharmacology: Clinical and Experimental 34:3, pages e2695.
Crossref
Crossref
Beatrice Benatti, Chiara Arici, A. Carlo Altamura & Bernardo Dell'Osso. (2019) Shared Obsessive-Compulsive Disorder. Journal of Nervous & Mental Disease 207:4, pages 311-313.
Crossref
Crossref
Leah D. Fryml, Christopher G. Pelic, Ron Acierno, Peter Tuerk, Matthew Yoder, Jeffrey J. Borckardt, Natasha Juneja, Matthew Schmidt, Kathryn L. Beaver & Mark S. George. (2019) Exposure Therapy and Simultaneous Repetitive Transcranial Magnetic Stimulation. The Journal of ECT 35:1, pages 53-60.
Crossref
Crossref
Gokcen Akyurek, Kubra Sahadet Sezer, Leyla Kaya & Kezban Temucin. 2019. Anxiety Disorders - From Childhood to Adulthood. Anxiety Disorders - From Childhood to Adulthood.
Geoffrey de Brouwer, Arina Fick, Brian H. Harvey & De Wet Wolmarans. (2018) A critical inquiry into marble-burying as a preclinical screening paradigm of relevance for anxiety and obsessive–compulsive disorder: Mapping the way forward. Cognitive, Affective, & Behavioral Neuroscience 19:1, pages 1-39.
Crossref
Crossref
Umberto Albert, Donatella Marazziti, Gabriele Di Salvo, Francesca Solia, Gianluca Rosso & Giuseppe Maina. (2019) A Systematic Review of Evidence-based Treatment Strategies for Obsessive- compulsive Disorder Resistant to first-line Pharmacotherapy. Current Medicinal Chemistry 25:41, pages 5647-5661.
Crossref
Crossref
Umberto Albert, Gabriele Di Salvo, Francesca Solia, Gianluca Rosso & Giuseppe Maina. (2019) Combining Drug and Psychological Treatments for Obsessive- Compulsive Disorder: What is the Evidence, When and for Whom. Current Medicinal Chemistry 25:41, pages 5632-5646.
Crossref
Crossref
Seon-Cheol Park & Yong-Ku Kim. (2019) A Novel Bio-Psychosocial-Behavioral Treatment Model of Panic Disorder. Psychiatry Investigation 16:1, pages 4-15.
Crossref
Crossref
Roseli Gedanke Shavitt & Juliana Belo Diniz. 2018. A Transdiagnostic Approach to Obsessions, Compulsions and Related Phenomena. A Transdiagnostic Approach to Obsessions, Compulsions and Related Phenomena
229
241
.
Benneth Ben-Azu, Ekene Enekabokom Nwoke, Adegbuyi Oladele Aderibigbe, Itivere Adrian Omogbiya, Abayomi Mayowa Ajayi, Elizabeth Toyin Olonode, Solomon Umukoro & Ezekiel O. Iwalewa. (2019) Possible neuroprotective mechanisms of action involved in the neurobehavioral property of naringin in mice. Biomedicine & Pharmacotherapy 109, pages 536-546.
Crossref
Crossref
. 2019. Therapie psychischer Erkrankungen. Therapie psychischer Erkrankungen
1
119
.
Marco Antonio Caldieraro & Paolo Cassano. 2019. Photobiomodulation in the Brain. Photobiomodulation in the Brain
479
487
.
Kang Soo Lee & Sang Hyuk Lee. 2019. Treatment Resistance in Psychiatry. Treatment Resistance in Psychiatry
207
214
.
Mu-Hong Chen & Shih-Jen Tsai. 2019. Treatment Resistance in Psychiatry. Treatment Resistance in Psychiatry
189
206
.
Joseph K. Carpenter, Kristina Conroy & Stefan G. Hofmann. 2018. The Cambridge Handbook of Anxiety and Related Disorders. The Cambridge Handbook of Anxiety and Related Disorders
771
804
.
Gavin Andrews, Caroline Bell, Philip Boyce, Christopher Gale, Lisa Lampe, Omar Marwat, Ronald Rapee & Gregory Wilkins. (2018) Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of panic disorder, social anxiety disorder and generalised anxiety disorder. Australian & New Zealand Journal of Psychiatry 52:12, pages 1109-1172.
Crossref
Crossref
Ainsley M. Sutherland, Judith Nicholls, James Bao & Hance Clarke. (2018) Overlaps in pharmacology for the treatment of chronic pain and mental health disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry 87, pages 290-297.
Crossref
Crossref
Displaying 200 of 498 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list